BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23374028)

  • 1. From pipeline to patient: new developments in cystic fibrosis therapeutics.
    Prayle AP; Smyth AR
    Expert Opin Pharmacother; 2013 Feb; 14(3):323-9. PubMed ID: 23374028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies for cystic fibrosis: what's in the pipeline?
    Frerichs C; Smyth A
    Expert Opin Pharmacother; 2009 May; 10(7):1191-202. PubMed ID: 19405793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging therapies in cystic fibrosis.
    Anderson P
    Ther Adv Respir Dis; 2010 Jun; 4(3):177-85. PubMed ID: 20530065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis therapeutics: the road ahead.
    Hoffman LR; Ramsey BW
    Chest; 2013 Jan; 143(1):207-213. PubMed ID: 23276843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New drug developments in the management of cystic fibrosis lung disease.
    Turnbull AR; Davies JC
    Expert Opin Pharmacother; 2016 Jun; 17(8):1103-12. PubMed ID: 27017976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and adverse effects of drugs used to treat adult cystic fibrosis.
    Chopra R; Paul L; Manickam R; Aronow WS; Maguire GP
    Expert Opin Drug Saf; 2015 Mar; 14(3):401-11. PubMed ID: 25604518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for cystic fibrosis.
    Amin R; Ratjen F
    Expert Opin Emerg Drugs; 2014 Mar; 19(1):143-55. PubMed ID: 24479826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFβ as a therapeutic target in cystic fibrosis.
    Kramer EL; Clancy JP
    Expert Opin Ther Targets; 2018 Feb; 22(2):177-189. PubMed ID: 29168406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and Emerging Treatments for Cystic Fibrosis.
    Barry PJ; Jones AM
    Drugs; 2015 Jul; 75(11):1165-75. PubMed ID: 26091951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Pulmonary Exacerbations in Cystic Fibrosis.
    Goss CH
    Semin Respir Crit Care Med; 2019 Dec; 40(6):792-803. PubMed ID: 31659730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy.
    Lommatzsch ST; Taylor-Cousar JL
    Ther Adv Respir Dis; 2019; 13():1753466619844424. PubMed ID: 31027466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on new and emerging therapies for cystic fibrosis.
    Hudock KM; Clancy JP
    Expert Opin Emerg Drugs; 2017 Dec; 22(4):331-346. PubMed ID: 29264936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs for cystic fibrosis.
    Wilschanski M; Kerem E
    Expert Opin Investig Drugs; 2011 Sep; 20(9):1285-92. PubMed ID: 21745147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
    Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
    Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and emerging therapies for pulmonary complications of cystic fibrosis.
    Tonelli MR; Aitken ML
    Drugs; 2001; 61(10):1379-85. PubMed ID: 11558827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway clearance devices for cystic fibrosis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(26):1-50. PubMed ID: 23074531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K and the management of patients with cystic fibrosis.
    Durie PR
    CMAJ; 1994 Oct; 151(7):933-6. PubMed ID: 7922929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic treatment of CF lung disease: from bench to bedside.
    Bals R; Hubert D; Tümmler B
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S146-51. PubMed ID: 21658633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic therapies in cystic fibrosis. Does standard therapy work?
    Marshall BC; Samuelson WM
    Clin Chest Med; 1998 Sep; 19(3):487-504, vi. PubMed ID: 9759551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.